scispace - formally typeset
Journal ArticleDOI

Idiopathic Pulmonary Fibrosis.

David J. Lederer, +1 more
- 09 May 2018 - 
- Vol. 378, Iss: 19, pp 1811-1823
Reads0
Chats0
TLDR
Idiopathic Pulmonary Fibrosis IdiopATHic pulmonary fibrosis appears to be increasing in incidence, and it requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression.
Abstract
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.

read more

Citations
More filters
Journal ArticleDOI

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

TL;DR: In patients with progressive fibrosing interstitial lung diseases, the annual rate of decline in the FVC was significantly lower among patients who received nintedanib than among those who received placebo.
Journal ArticleDOI

New insights into TGF-β/Smad signaling in tissue fibrosis.

TL;DR: An overview of the molecular mechanisms of TGF-β/Smad signaling pathway in renal, hepatic, pulmonary and cardiac fibrosis is presented and particular challenges are presented and placed within the context of future applications against tissue fibrosis.
Journal ArticleDOI

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.

TL;DR: A single-cell atlas of idiopathic pulmonary fibrosis (IPF), a fatal interstitial lung disease, is provided by profiling 312,928 cells from 32 IPF, 28 smoker and nonsmoker controls, and 18 chronic obstructive pulmonary disease (COPD) lungs.
References
More filters
Journal ArticleDOI

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

TL;DR: Although lung cancer screening is not an alternative to smoking cessation, the USPSTF found adequate evidence that annual screening for lung cancer with LDCT in a defined population of high-risk persons can prevent a substantial number of lung cancerrelated deaths.
Journal ArticleDOI

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

TL;DR: Increased risks of death and hospitalization were observed in patients with idiopathic pulmonary fibrosis who were treated with a combination of prednisone, azathioprine, and NAC, as compared with placebo, providing evidence against the use of this combination in such patients.
Journal ArticleDOI

Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

TL;DR: In this paper, the authors found that mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis, which is a rare hereditary disorder associated with premature death from aplastic anemia and lung fibrosis.
Related Papers (5)